Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1991 Aug;85(2):278–281. doi: 10.1111/j.1365-2249.1991.tb05718.x

Abnormalities within CD4 and CD8 T lymphocytes subsets in type 1 (insulin-dependent) diabetes.

J Ilonen 1, H M Surcel 1, M L Käär 1
PMCID: PMC1535750  PMID: 1677834

Abstract

Abnormalities in the proportions of various T lymphocyte subpopulations have been found in a number of autoimmune diseases. Monoclonal antibodies labelled with various fluorochromes were used here to define the percentages of subsets, and especially to divide CD4+ (helper/inducer) and CD8+ (suppressor/cytotoxic) cells into phenotypic subgroups. Blood samples were analysed from 25 patients (age 10.1 +/- 3.7 years) with recently diagnosed insulin-dependent diabetes mellitus (IDDM) and 25 age- and sex-matched control subjects. The percentages of CD4+ cells and CD4+CD45RA+ cells described as naive T helper cells or suppressor/inducers were increased in the IDDM patients (P less than 0.05 and P less than 0.05. Student's t-test, respectively), whereas the percentage of CD4+CD45RA- cells (memory T-helper cells, helper/inducers) was similar in the patients and controls. The percentage of CD8+CD11b+ cells containing suppressor/effector lymphocytes was decreased in the IDDM patients as compared with the controls (P less than 0.01) but no significant difference was seen in total CD8+ cells. The percentages of CD3+ cells and the proportions of these simultaneously positive for HLA-DR antigen (activated T cells) were also increased in the recent IDDM patients (P less than 0.001 and P less than 0.05, respectively), while the proportion of CD20+ B cells was decreased (P less than 0.05). The findings support the view that disturbed immune regulation occurs in IDDM and indicate that further division of T cell subpopulations may clarify our understanding of the disease process.

Full text

PDF
278

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Sakkaf L., Pozzilli P., Tarn A. C., Schwarz G., Gale E. A., Bottazzo G. F. Persistent reduction of CD4/CD8 lymphocyte ratio and cell activation before the onset of type 1 (insulin-dependent) diabetes. Diabetologia. 1989 May;32(5):322–325. doi: 10.1007/BF00265550. [DOI] [PubMed] [Google Scholar]
  2. Buschard K., Röpke C., Madsbad S., Mehlsen J., Rygaard J. T lymphocyte subsets in patients with newly diagnosed type 1 (insulin-dependent) diabetes: a prospective study. Diabetologia. 1983 Sep;25(3):247–251. doi: 10.1007/BF00279938. [DOI] [PubMed] [Google Scholar]
  3. Carney W. P., Rubin R. H., Hoffman R. A., Hansen W. P., Healey K., Hirsch M. S. Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis. J Immunol. 1981 Jun;126(6):2114–2116. [PubMed] [Google Scholar]
  4. Chofflon M., Weiner H. L., Morimoto C., Hafler D. A. Decrease of suppressor inducer (CD4+2H4+) T cells in multiple sclerosis cerebrospinal fluid. Ann Neurol. 1989 May;25(5):494–499. doi: 10.1002/ana.410250512. [DOI] [PubMed] [Google Scholar]
  5. Clement L. T., Dagg M. K., Landay A. Characterization of human lymphocyte subpopulations: alloreactive cytotoxic T-lymphocyte precursor and effector cells are phenotypically distinct from Leu 2+ suppressor cells. J Clin Immunol. 1984 Sep;4(5):395–402. doi: 10.1007/BF00917143. [DOI] [PubMed] [Google Scholar]
  6. De Berardinis P., Londei M., Kahan M., Balsano F., Kontiainen S., Gale E. A., Bottazzo G. F., Feldmann M. The majority of the activated T cells in the blood of insulin-dependent diabetes mellitus (IDDM) patients are CD4+. Clin Exp Immunol. 1988 Aug;73(2):255–259. [PMC free article] [PubMed] [Google Scholar]
  7. De Waele M., Thielemans C., Van Camp B. K. Characterization of immunoregulatory T cells in EBV-induced infectious mononucleosis by monoclonal antibodies. N Engl J Med. 1981 Feb 19;304(8):460–462. doi: 10.1056/NEJM198102193040804. [DOI] [PubMed] [Google Scholar]
  8. Emery P., Gentry K. C., Mackay I. R., Muirden K. D., Rowley M. Deficiency of the suppressor inducer subset of T lymphocytes in rheumatoid arthritis. Arthritis Rheum. 1987 Aug;30(8):849–856. doi: 10.1002/art.1780300802. [DOI] [PubMed] [Google Scholar]
  9. Faustman D., Eisenbarth G., Daley J., Breitmeyer J. Abnormal T-lymphocyte subsets in type I diabetes. Diabetes. 1989 Nov;38(11):1462–1468. doi: 10.2337/diab.38.11.1462. [DOI] [PubMed] [Google Scholar]
  10. Galluzzo A., Giordano C., Rubino G., Bompiani G. D. Immunoregulatory T-lymphocyte subset deficiency in newly diagnosed type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1984 Jun;26(6):426–430. doi: 10.1007/BF00262214. [DOI] [PubMed] [Google Scholar]
  11. Gupta S., Fikrig S. M., Khanna S., Orti E. Deficiency of suppressor T-cells in insulin-dependent diabetes mellitus: an analysis with monoclonal antibodies. Immunol Lett. 1982 May;4(5):289–294. doi: 10.1016/0165-2478(82)90054-2. [DOI] [PubMed] [Google Scholar]
  12. Herold K. C., Huen A., Gould L., Traisman H., Rubenstein A. H. Alterations in lymphocyte subpopulations in type 1 (insulin-dependent) diabetes mellitus: exploration of possible mechanisms and relationships to autoimmune phenomena. Diabetologia. 1984 Jul;27 (Suppl):102–105. doi: 10.1007/BF00275660. [DOI] [PubMed] [Google Scholar]
  13. Hitchcock C. L., Riley W. J., Alamo A., Pyka R., Maclaren N. K. Lymphocyte subsets and activation in prediabetes. Diabetes. 1986 Dec;35(12):1416–1422. doi: 10.2337/diab.35.12.1416. [DOI] [PubMed] [Google Scholar]
  14. Horita M., Suzuki H., Onodera T., Ginsberg-Fellner F., Fauci A. S., Notkins A. L. Abnormalities of immunoregulatory T cell subsets in patients with insulin-dependent diabetes mellitus. J Immunol. 1982 Oct;129(4):1426–1429. [PubMed] [Google Scholar]
  15. Hyypiä T., Eskola J., Laine M., Meurman O. B-cell function in vitro during rubella infection. Infect Immun. 1984 Feb;43(2):589–592. doi: 10.1128/iai.43.2.589-592.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hyöty H. Flow-cytometric analysis of lymphocyte subsets in relation to virus infections at the onset of type 1 (insulin-dependent) diabetes. APMIS. 1988 Aug;96(8):741–748. doi: 10.1111/j.1699-0463.1988.tb00939.x. [DOI] [PubMed] [Google Scholar]
  17. Ilonen J., Surcel H. M., Mustonen A., Kär M. L., Akerblom H. K. Lymphocyte subpopulations at the onset of type 1 (insulin-dependent) diabetes. Diabetologia. 1984 Jul;27 (Suppl):106–108. doi: 10.1007/BF00275661. [DOI] [PubMed] [Google Scholar]
  18. Jackson R. A., Morris M. A., Haynes B. F., Eisenbarth G. S. Increased circulating Ia-antigen-bearing T cells in type I diabetes mellitus. N Engl J Med. 1982 Apr 1;306(13):785–788. doi: 10.1056/NEJM198204013061305. [DOI] [PubMed] [Google Scholar]
  19. Landay A., Gartland G. L., Clement L. T. Characterization of a phenotypically distinct subpopulation of Leu-2+ cells that suppresses T cell proliferative responses. J Immunol. 1983 Dec;131(6):2757–2761. [PubMed] [Google Scholar]
  20. Mascart-Lemone F., Delespesse G., Dorchy H., Lemiere B., Servais G. Characterization of immunoregulatory T lymphocytes in insulin-dependent diabetic children by means of monoclonal antibodies. Clin Exp Immunol. 1982 Feb;47(2):296–300. [PMC free article] [PubMed] [Google Scholar]
  21. Morimoto C., Steinberg A. D., Letvin N. L., Hagan M., Takeuchi T., Daley J., Levine H., Schlossman S. F. A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody. J Clin Invest. 1987 Mar;79(3):762–768. doi: 10.1172/JCI112882. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Pitzalis C., Kingsley G., Murphy J., Panayi G. Abnormal distribution of the helper-inducer and suppressor-inducer T-lymphocyte subsets in the rheumatoid joint. Clin Immunol Immunopathol. 1987 Nov;45(2):252–258. doi: 10.1016/0090-1229(87)90040-7. [DOI] [PubMed] [Google Scholar]
  23. Pontesilli O., Chase H. P., Carotenuto P., Herberger M. J., Hayward A. R. T-lymphocyte subpopulations in insulin-dependent (type I) diabetes mellitus. Clin Exp Immunol. 1986 Jan;63(1):68–72. [PMC free article] [PubMed] [Google Scholar]
  24. Quiniou-Debrie M. C., Debray-Sachs M., Dardenne M., Czernichow P., Assan R., Bach J. F. Anti-islet cellular and humoral immunity, T-cell subsets, and thymic function in type I diabetes. Diabetes. 1985 Apr;34(4):373–379. doi: 10.2337/diab.34.4.373. [DOI] [PubMed] [Google Scholar]
  25. Rodier M., Andary M., Richard J. L., Mirouze J., Clot J. Peripheral blood T-cell subsets studied by monoclonal antibodies in type 1 (insulin-dependent) diabetes: effect of blood glucose control. Diabetologia. 1984 Jul;27 (Suppl):136–138. doi: 10.1007/BF00275671. [DOI] [PubMed] [Google Scholar]
  26. Rose L. M., Ginsberg A. H., Rothstein T. L., Ledbetter J. A., Clark E. A. Fluctuations of CD4+ T-cell subsets in remitting-relapsing multiple sclerosis. Ann Neurol. 1988 Aug;24(2):192–199. doi: 10.1002/ana.410240204. [DOI] [PubMed] [Google Scholar]
  27. Rose L. M., Ginsberg A. H., Rothstein T. L., Ledbetter J. A., Clark E. A. Selective loss of a subset of T helper cells in active multiple sclerosis. Proc Natl Acad Sci U S A. 1985 Nov;82(21):7389–7393. doi: 10.1073/pnas.82.21.7389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Salonen R., Ilonen J., Jägerroos H., Syrjälä H., Nurmi T., Reunanen M. Lymphocyte subsets in the cerebrospinal fluid in active multiple sclerosis. Ann Neurol. 1989 May;25(5):500–502. doi: 10.1002/ana.410250513. [DOI] [PubMed] [Google Scholar]
  29. Sanders M. E., Makgoba M. W., Shaw S. Human naive and memory T cells: reinterpretation of helper-inducer and suppressor-inducer subsets. Immunol Today. 1988 Jul-Aug;9(7-8):195–199. doi: 10.1016/0167-5699(88)91212-1. [DOI] [PubMed] [Google Scholar]
  30. Surcel H. M., Ilonen J., Kär M. L., Hyöty H., Leinikki P. Infection by multiple viruses and lymphocyte abnormalities at the diagnosis of diabetes. Acta Paediatr Scand. 1988 May;77(3):471–474. doi: 10.1111/j.1651-2227.1988.tb10684.x. [DOI] [PubMed] [Google Scholar]
  31. Swain S. L. T cell subsets and the recognition of MHC class. Immunol Rev. 1983;74:129–142. doi: 10.1111/j.1600-065x.1983.tb01087.x. [DOI] [PubMed] [Google Scholar]
  32. al-Kassab A. S., Raziuddin S. Immune activation and T cell subset abnormalities in circulation of patients with recently diagnosed type I diabetes mellitus. Clin Exp Immunol. 1990 Aug;81(2):267–271. doi: 10.1111/j.1365-2249.1990.tb03329.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES